Similar articles

• Adrenocortical suppression in workers manufacturing synthetic glucocorticoids.

  Newton RW, Browning MC, Iqbal J, Piercy N, Adamson DG. Newton RW, et al. Br Med J. 1978 Jan 14;1(6105):73-4. doi: 10.1136/bmj.1.6105.73. Br Med J. 1978. PMID: 620203 Free PMC article.
• Adrenocortical suppression in workers employed in manufacturing synthetic glucocorticosteroids: solutions to a problem.

  Newton RW, Browning MC, Nicholson PC, Mowat DA. Newton RW, et al. Br J Ind Med. 1982 May;39(2):179-82. doi: 10.1136/oem.39.2.179. Br J Ind Med. 1982. PMID: 6461351 Free PMC article.
• Asthma in workers manufacturing cephalosporins.

  Coutts II, Dally MB, Taylor AJ, Pickering CA, Horsfield N. Coutts II, et al. Br Med J (Clin Res Ed). 1981 Oct 10;283(6297):950. doi: 10.1136/bmj.283.6297.950. Br Med J (Clin Res Ed). 1981. PMID: 6793187 Free PMC article. No abstract available.
• Occupational toxicology: test methods and approaches for the pharmaceutical industry.

  Sprague G, Sutton T. Sprague G, et al. Occup Med. 1997 Jan-Mar;12(1):119-29. Occup Med. 1997. PMID: 9153057 Review.
• [Pathological manifestations in workers engaged in the production or administration of cytostatic drugs].

  Nava C, Briatico Vangosa G, Forni A. Nava C, et al. Boll Chim Farm. 1984 Dec;123(12):547-51. Boll Chim Farm. 1984. PMID: 6398701 Review. Italian. No abstract available.